# FDA recall D-0840-2020

> **B AND A TRADING CORPORATION** · Class II · drug recall initiated 2020-01-28.

## Product

Kushim Tablets (Gushim) 45-count packages, Label in foreign language

## Reason for recall

Marketed Without an Approved NDA/ANDA. FDA analysis found product to contain cinobufagin, bufalin, and bufotenine

## Distribution

NY & NJ only

## Key facts

- **Recall number:** D-0840-2020
- **Recalling firm:** B AND A TRADING CORPORATION
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2020-01-28
- **Report date:** 2020-02-19
- **Termination date:** 2023-12-21

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Carlstadt, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0840-2020

## Citation

> AI Analytics. FDA recall D-0840-2020. Retrieved 2026-05-27 from https://api.ai-analytics.org/recall/D-0840-2020. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*